K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue Warrants in...
K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock COMPANY ANNOUNCES AGREEMENT OF TERMS...
K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011 PR Newswire ST. LOUIS, Feb. 4, 2011 ST. LOUIS, Feb. 4, 2011...
K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™ PR Newswire ST. LOUIS, Jan. 12, 2011 ST. LOUIS, Jan. 12, 2011...
K-V Pharmaceutical Co. (KVA, KVB) has reached a $20 million loan agreement in the wake of a recent U.S. Food and Drug Administration approval as...
K-V Pharmaceutical Co. (KVA, KVB) has received permission from the U.S. Food and Drug Administration to return its first product to market...
Watson Pharmaceuticals Inc. (WPI) has grabbed a large share of the market for a generic version of AstraZeneca PLC's (AZN, AZN.LN) blood pressure...
Watson Pharmaceuticals Inc. (WPI) has grabbed a large share of the market for a generic version of AstraZeneca Plc's (AZN AZN.LN) blood pressure...
ST. LOUIS, Jan. 11 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced it has entered into an amendment to the...
ST. LOUIS, Jan. 7 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced that IVS Associates, Inc., the inspector of...
ST. LOUIS, Dec. 15 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced that on December 10, 2009, the Company...
ST. LOUIS, Dec. 2 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced that that it has entered into an employment...
ST. LOUIS, Nov. 13 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced that IVS Associates, Inc., the inspector...
Quality control issues and shortages at several smaller generic drug makers have brought increased price stability for the larger players in the...
ST. LOUIS, Sept. 21 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE:KVa/KVb) today announced the sale to Perrigo Company (NASDAQ:PRGO...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.